189 related articles for article (PubMed ID: 12570757)
1. Medicinal chemistry of adenosine A2A receptor agonists.
Cristalli G; Lambertucci C; Taffi S; Vittori S; Volpini R
Curr Top Med Chem; 2003; 3(4):387-401. PubMed ID: 12570757
[TBL] [Abstract][Full Text] [Related]
2. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
[TBL] [Abstract][Full Text] [Related]
3. Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists.
Volpini R; Costanzi S; Lambertucci C; Vittori S; Cristalli G
Curr Pharm Des; 2002; 8(26):2285-98. PubMed ID: 12369946
[TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry and pharmacology of A2B adenosine receptors.
Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN
Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760
[TBL] [Abstract][Full Text] [Related]
5. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA.
Camaioni E; Di Francesco E; Vittori S; Volpini R; Cristalli G
Bioorg Med Chem; 1997 Dec; 5(12):2267-75. PubMed ID: 9459024
[TBL] [Abstract][Full Text] [Related]
6. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
Conti A; Lozza G; Monopoli A
Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
[TBL] [Abstract][Full Text] [Related]
7. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
Sanjani MS; Teng B; Krahn T; Tilley S; Ledent C; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2322-33. PubMed ID: 21949117
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
9. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
[TBL] [Abstract][Full Text] [Related]
11. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.
Gao ZG; Mamedova LK; Chen P; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1985-93. PubMed ID: 15476669
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
13. 2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor.
van Tilburg EW; von Frijtag Drabbe Kunzel J; de Groote M; IJzerman AP
J Med Chem; 2002 Jan; 45(2):420-9. PubMed ID: 11784146
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
El-Tayeb A; Gollos S
Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
[TBL] [Abstract][Full Text] [Related]
15. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
[TBL] [Abstract][Full Text] [Related]
16. A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists.
Cristalli G; Lambertucci C; Marucci G; Volpini R; Dal Ben D
Curr Pharm Des; 2008; 14(15):1525-52. PubMed ID: 18537675
[TBL] [Abstract][Full Text] [Related]
17. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A(2A) receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits.
de Brito MT; Canto A; Correia JH; Cunha RA; Marques MC
Br J Pharmacol; 2002 Mar; 135(5):1324-30. PubMed ID: 11877342
[TBL] [Abstract][Full Text] [Related]
19. 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
Cristalli G; Camaioni E; Vittori S; Volpini R; Borea PA; Conti A; Dionisotti S; Ongini E; Monopoli A
J Med Chem; 1995 Apr; 38(9):1462-72. PubMed ID: 7739005
[TBL] [Abstract][Full Text] [Related]
20. Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.
Beukers MW; den Dulk H; van Tilburg EW; Brouwer J; Ijzerman AP
Mol Pharmacol; 2000 Dec; 58(6):1349-56. PubMed ID: 11093773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
